Evidence map›Paper›PMID 41888351›Full record

ArticleScientific reports2026

Correction: Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy.

Nianqiu Liu, Weihan Cao, Jiefu Tang, Ruimei Dong, Juan Guo, Zhuang Luo, Qian Yao, Song Teng, Zhuoxuan Liang, Yuntao Yang and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Nianqiu Liu *The Key Laboratory of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan, China.
Weihan Cao *The Department of Ultrasound, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Jiefu TangThe Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Ruimei DongThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Juan GuoThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Zhuang LuoThe Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Qian YaoThe Institute of Yunnan Tumor, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Song TengThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Zhuoxuan LiangThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Yuntao YangThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Menying GuThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Jie ZhouThe Key Laboratory of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan, China.
Wenlin ChenThe Key Laboratory of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, Yunnan, China.
Hongmin LiangThe Department of Ultrasound, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. kmlianghongmin@163.com.
Xiaoqiong HeThe School of Public Health, Kunming Medical University, Kunming, Yunnan, China. hexiaoqiong@kmmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41888351
PMCPMC13022298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.